AAOpt 2024: Looking at optometry's evolution and expansion

Commentary
Article

Justin Schweitzer, OD, FAAO; Selina McGee, OD; and Ian Ben Gaddie, OD, FAAO; delve into how optometry has changed in the past year.

As the field of optometry continues to evolve, it is crucial for practitioners to stay informed about the latest advancements and innovations. Fortunately, a dynamic presentation at the upcoming AAOpt conference promises to provide optometrists with a comprehensive overview of the exciting developments shaping the profession. Titled "Optometry's Evolution and Expansion," this 2-hour rapid-fire lecture will feature a collaborative effort from three renowned experts in the field: Justin Schweitzer, OD, FAAO; Selina McGee, OD; and Ian Ben Gaddie, OD, FAAO. Together, they will delve into a wide range of topics that are transforming the way optometrists diagnose and manage various eye conditions. "We're going to talk about a ton of different things that are either on the market or coming into the market in a variety of different spaces," explains Schweitzer. "We're talking a lot on dry eye and some of the new innovations in that market, which is just massive and huge and it can help a lot of our patients."

Beyond the burgeoning dry eye landscape, the presenters will also explore the latest advancements in the glaucoma space, covering both technological and pharmaceutical innovations. Additionally, they will showcase some of the cutting-edge diagnostic tools that are revolutionizing the way optometrists identify and monitor various ocular surface and posterior segment conditions. "I think that we always have to be on the cutting edge of new technology and new innovations within our profession," emphasizes Schweitzer. "And you'll see that as we go through this, some of the topics that we're going to cover."

Even the presenters themselves were surprised by the wealth of information they uncovered while preparing for this lecture. "Dr. McGee presented to me essentially when we were putting this talk together, and I was unaware of certain things. Dr. Gaddie, same thing – we kind of learned together as we were putting this together, because there's so much new stuff, exciting stuff that's coming to the market." Attendees of this dynamic presentation can expect to leave feeling empowered and informed, ready to incorporate the latest advancements into their clinical practice. By staying at the forefront of optometry's evolution, practitioners can ensure they provide the highest level of care for their patients.

Schweitzer is presenting 3 presentations at this year's AAOpt meeting. You can watch his interview on new developments in ocular drug delivery here.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.